Efferocytosis and autoimmune disease
International Immunology · 14.11.2018 · 30 (12) · 551-558
DOI: 10.1093/intimm/dxy055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 24.08.2018. Verfasst von Mahiru Kawano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry & Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Core Research for Evolutional Science and Technology, Japan Science and Technology Agency.
Abstract (Originalsprache)
An enormous number of cells in the body die by apoptosis during development and under homeostasis. Apoptotic cells are swiftly engulfed by macrophages and digested into units. This removal of apoptotic cells is called ‘efferocytosis’. For efferocytosis, macrophages recognize phosphatidylserine (PtdSer) exposed on the cell surface as an ‘eat me’ signal. In healthy cells, PtdSer is exclusively localized to the inner leaflet of the plasma membrane by the action of flippases. When cells undergo apoptosis, caspase cleaves flippases to inactivate them, while it cleaves pro-scramblases to active scramblases, which quickly translocate PtdSer to the cell surface. The PtdSer is then recognized by PtdSer-binding proteins or by PtdSer receptors on macrophages, which subsequently engulf the apoptotic cells. When efferocytosis fails, apoptotic cells can rupture, releasing cellular materials that can evoke an autoimmune response. Thus, a defect in the PtdSer-exposing or PtdSer-recognizing processes triggers autoimmunity, leading to a systemic lupus erythematosus-type autoimmune disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Biochemistry & Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
Förderung
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology
- Japan Science and Technology Agency
Zitieren
APA
Kawano, M., & Nagata, S. (2018). Efferocytosis and autoimmune disease. International Immunology, 30(12), 551-558. https://doi.org/10.1093/intimm/dxy055
Vancouver
Kawano M, Nagata S. Efferocytosis and autoimmune disease. International Immunology. 2018;30(12):551-558. doi:10.1093/intimm/dxy055
BibTeX
@article{Kawano2018,
author = {Kawano, Mahiru and Nagata, Shigekazu},
title = {Efferocytosis and autoimmune disease},
journal = {International Immunology},
year = {2018},
volume = {30},
number = {12},
pages = {551--558},
doi = {10.1093/intimm/dxy055}
}
EUVIMED